Though there is limited evidence on the use of IV versus oral iron in patients with CKD, as per the KDIGO guideline, findings from a number of studies assessing the efficacy of IV iron have been published, including this article. IV iron may be the preferred initial treatment option for physicians wanting to increase Hb concentrations or delay alternative anaemia management in patients with chronic kidney disease. This evidence concerns the gene GSTM1 and anemia.